Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Sugawara

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neuropsychiatric Disease and Treatment|March 14, 2019
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case seriesYuka Sugawara Kikuchi, Tetsuo Shimizu
Clinical Kidney Journal|November 25, 2024
Telemedicine in nephrology: future perspective and solutionsYuka Sugawara, Yosuke Hirakawa, Masaomi Nangaku
Journal of Diabetes Investigation|April 2, 2026
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney diseaseYosuke Hirakawa, Yuka Sugawara, Masaomi Nangaku
Psychiatry Investigation|April 6, 2019
Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant SchizophreniaYuka Sugawara Kikuchi, Takashi Kanbayashi, Tetsuo Shimizu
Neuropsychiatric Disease and Treatment|June 24, 2008
Marked effect of milnacipran combined with olanzapine for a delusional depressive patientYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.
Clinical Neuropharmacology|August 3, 2005
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case reportHisashi Higuchi, Mitsuhiro Kamata, Yuka Sugawara, et al.
Nephrology (Carlton, Vic.)|July 15, 2025
Coronavirus Disease 2019 Vaccination Booster Effectiveness Based on the 2022 Japanese Dialysis RegistryYuka Sugawara, Masao Iwagami, Yuki Sakurai, et al.
Annals of Clinical Biochemistry|December 10, 2016
Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphismsYumiko Akamine, Yuka Sugawara-Kikuchi, Tsukasa Uno, et al.
Journal of Diabetes Investigation|April 8, 2025
Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive studyToyohiro Hashiba, Yuka Sugawara, Yosuke Hirakawa, et al.
Online Journal of Public Health Informatics|July 15, 2026
Trend in Devices and Digital Tools for Remote Consultation From Medical Providers to Specialists: Scoping ReviewRisa Hara, Yosuke Hirakawa, Yuka Sugawara, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|March 14, 2019
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case seriesYuka Sugawara Kikuchi, Tetsuo Shimizu
Clinical Kidney Journal|November 25, 2024
Telemedicine in nephrology: future perspective and solutionsYuka Sugawara, Yosuke Hirakawa, Masaomi Nangaku
Journal of Diabetes Investigation|April 2, 2026
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney diseaseYosuke Hirakawa, Yuka Sugawara, Masaomi Nangaku
Psychiatry Investigation|April 6, 2019
Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant SchizophreniaYuka Sugawara Kikuchi, Takashi Kanbayashi, Tetsuo Shimizu
Neuropsychiatric Disease and Treatment|June 24, 2008
Marked effect of milnacipran combined with olanzapine for a delusional depressive patientYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.
Clinical Neuropharmacology|August 3, 2005
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case reportHisashi Higuchi, Mitsuhiro Kamata, Yuka Sugawara, et al.
Nephrology (Carlton, Vic.)|July 15, 2025
Coronavirus Disease 2019 Vaccination Booster Effectiveness Based on the 2022 Japanese Dialysis RegistryYuka Sugawara, Masao Iwagami, Yuki Sakurai, et al.
Annals of Clinical Biochemistry|December 10, 2016
Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphismsYumiko Akamine, Yuka Sugawara-Kikuchi, Tsukasa Uno, et al.
Journal of Diabetes Investigation|April 8, 2025
Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive studyToyohiro Hashiba, Yuka Sugawara, Yosuke Hirakawa, et al.
Online Journal of Public Health Informatics|July 15, 2026
Trend in Devices and Digital Tools for Remote Consultation From Medical Providers to Specialists: Scoping ReviewRisa Hara, Yosuke Hirakawa, Yuka Sugawara, et al.
Pageof 4